Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St indexes eye weekly losses; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Clearside Biomedical (CLSD) IPO Opens Up 14%
June 2, 2016 11:17 AM EDTToday's IPO for Clearside Biomedical, Inc. (Nasdaq: CLSD) opened for trading at $8 after pricing 7,200,000 shares of its common stock at a public offering price of $7.00 per share.
Cowen and Company and Stifel are serving as joint book-running managers for the offering. Needham &... More
